| Prevalence of orthostatic hypotension in Parkinson’s disease JM Senard, S Rai, M Lapeyre-Mestre, C Brefel, O Rascol, A Rascol, ... Journal of Neurology, Neurosurgery & Psychiatry 63 (5), 584-589, 1997 | 486 | 1997 |
| Adverse drug reactions and off-label drug use in paediatric outpatients B Horen, JL Montastruc, M Lapeyre-Mestre British journal of clinical pharmacology 54 (6), 665, 2002 | 408 | 2002 |
| Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database JL Montastruc, A Sommet, H Bagheri, M Lapeyre-Mestre British journal of clinical pharmacology 72 (6), 905, 2011 | 404 | 2011 |
| French health insurance databases: what interest for medical research? G Moulis, M Lapeyre-Mestre, A Palmaro, G Pugnet, JL Montastruc, ... La Revue de médecine interne 36 (6), 411-417, 2015 | 361 | 2015 |
| Prescription of drugs during pregnancy in France I Lacroix, C Damase-Michel, M Lapeyre-Mestre, JL Montastruc The Lancet 356 (9243), 1735-1736, 2000 | 361 | 2000 |
| Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France G Moulis, A Palmaro, JL Montastruc, B Godeau, M Lapeyre-Mestre, ... Blood, The Journal of the American Society of Hematology 124 (22), 3308-3315, 2014 | 359 | 2014 |
| Pharmacovigilance of self-medication JL Montastruc, H Bagheri, T Geraud, M Lapeyre-Mestre Therapie 52 (2), 105-110, 1997 | 257 | 1997 |
| A study of salivary secretion in Parkinson's disease H Bagheri, C Damase-Michel, M Lapeyre-Mestre, S Cismondo, ... Clinical neuropharmacology 22 (4), 213-215, 1999 | 236 | 1999 |
| Anxious and depressive symptoms in Parkinson's disease: the French cross‐sectionnal DoPaMiP study L Nègre‐Pagès, H Grandjean, M Lapeyre‐Mestre, JL Montastruc, ... Movement Disorders 25 (2), 157-166, 2010 | 218 | 2010 |
| Off-label prescribing of antipsychotics in adults, children and elderly individuals: a systematic review of recent prescription trends L Carton, O Cottencin, M Lapeyre-Mestre, P A Geoffroy, J Favre, N Simon, ... Current pharmaceutical design 21 (23), 3280-3297, 2015 | 217 | 2015 |
| Cannabis use: signal of increasing risk of serious cardiovascular disorders E Jouanjus, M Lapeyre‐Mestre, J Micallef, ... Journal of the American Heart Association 3 (2), e000638, 2014 | 217 | 2014 |
| Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey P Olivier, L Bertrand, M Tubery, D Lauque, JL Montastruc, ... Drugs & aging 26, 475-482, 2009 | 199 | 2009 |
| What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review E Jouanjus, V Raymond, M Lapeyre-Mestre, V Wolff Current atherosclerosis reports 19, 1-15, 2017 | 136 | 2017 |
| Exercise training for managing behavioral and psychological symptoms in people with dementia: a systematic review and meta-analysis P de Souto Barreto, L Demougeot, F Pillard, M Lapeyre-Mestre, Y Rolland Ageing research reviews 24, 274-285, 2015 | 136 | 2015 |
| Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods JL Montastruc, A Sommet, I Lacroix, P Olivier, G Durrieu, ... Joint Bone Spine 73 (6), 629-632, 2006 | 133 | 2006 |
| Off-label prescribing in pediatric outpatients A Palmaro, R Bissuel, N Renaud, G Durrieu, B Escourrou, S Oustric, ... Pediatrics 135 (1), 49-58, 2015 | 124 | 2015 |
| Cannabis‐related hospitalizations: unexpected serious events identified through hospital databases E Jouanjus, F Leymarie, M Tubery, M Lapeyre‐Mestre British journal of clinical pharmacology 71 (5), 758-765, 2011 | 123 | 2011 |
| Trends in use of antipsychotics in elderly patients with dementia: impact of national safety warnings A Gallini, S Andrieu, JM Donohue, N Oumouhou, M Lapeyre-Mestre, ... European Neuropsychopharmacology 24 (1), 95-104, 2014 | 121 | 2014 |
| Severe necrotizing soft‐tissue infections and nonsteroidal anti‐inflammatory drugs C Souyri, P Olivier, S Grolleau, M Lapeyre‐Mestre, ... Clinical and experimental dermatology 33 (3), 249-255, 2008 | 121 | 2008 |
| French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications E Jouanjus, M Lapeyre-Mestre, J Micallef Cannabis use: signal of increasing risk of serious cardiovascular disorders …, 2014 | 119 | 2014 |
